Annual Congress: Hematologic Malignancies


Registration Now Open!

NCCN 2021 Virtual Congress: Hematologic Malignancies™
Thursday, October 14, 2021 – Saturday, October 16, 2021

Register Now

Attention NCCN Member Institution Professionals! NCCN is offering complimentary registrations to healthcare professionals employed at our NCCN Member Institutions. For immediate access to this discount code and to continue your complimentary registration, please login to the NCCN Member Portal.

New format this year! The event has expanded to three days of interactive presentations for a variety of hematologic malignancies. Co-chairs Ranjana H. Advani, MD, Stanford Cancer Institute, and Andrew D. Zelenetz, MD, PhD, Memorial Sloan Kettering Cancer Center, will lead expert discussions on the latest advances, updates to the NCCN Guidelines®, and unique and challenging patient cases.

View Agenda


Agenda topics include:

  • Acute Lymphoblastic Leukemia
  • Acute Myeloid Leukemia
  • Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
  • Chronic Myeloid Leukemia
  • Diffuse Large B-Cell Lymphoma
  • Follicular Lymphoma
  • Histiocytic Neoplasms
  • Hodgkin Lymphoma
  • Mantle Cell Lymphoma
  • Marginal Zone Lymphomas
  • Monoclonal Gammopathy of Clinical Significance
  • Multiple Myeloma
  • Myeloproliferative Neoplasms
  • Non-Hodgkin Lymphomas
  • Plasma Cell Neoplasms
  • Peripheral T-Cell Lymphomas
  • Systemic Light Chain Amyloidosis
  • Waldenström Macroglobulinemia


Supported by educational grants from: AstraZeneca; Daiichi Sankyo; Gilead Sciences, Inc. and Kite, A Gilead Company; Novartis; Pharmacyclics LLC, an AbbVie Company and Janssen Biotech, Inc. administered by Janssen Scientific Affairs, LLC; and Seagen Inc. (formerly Seattle Genetics, Inc.). This educational activity is supported by a medical education grant from Karyopharm® Therapeutics. This activity is supported by an independent medical education grant from Pharmacyclics LLC and Janssen. This activity is supported by an independent educational grant from Merck & Co., Inc.


This program is approved for AMA PRA Category 1 Credit™ for physicians and will award contact hours for nurses, pharmacists, and other health care professionals.

Supporter Opportunities

Organizations who are interested in supporting NCCN CE programs are encouraged to contact Lisa Perfidio.
Sponsorship and exhibit opportunities are available. For more information, contact Jennifer Tredwell.

Members of the Media

Please contact Rachel Darwin.

Exhibitor Information

View Sponsor and Exhibitor Prospectus

Virtual Nursing Forum

Friday, October 8, 2021


This program provides hematology/oncology nurses with comprehensive and clinically relevant information to optimize patient education and care.


The NCCN 2020 Virtual Congress: Hematologic Malignancies™ and NCCN Virtual Nursing Forum: Advancing Oncology Nursing in Hematologic Malignancies™ were held October 8 – 10, 2020. These programs focused on updates to the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®); new, emerging and novel therapeutic agents; advances in cancer care; and the practical management of patients with hematologic malignancies.

View Recorded Sessions

CE-certified recorded sessions are available at and!

Those who attended the virtual events will be able to access session recordings, exhibition hall information, and other features in the Pathable platform through August 2021. Please email with questions.


Save the dates!

NCCN 2022 Annual Congress: Hematologic Malignancies™
New York Marriott Marquis • New York, New York
Friday, October 14, 2022 – Saturday, October 15, 2022

NCCN 2023 Annual Congress: Hematologic Malignancies™
Hilton San Francisco Union Square • San Francisco, California
Friday, September 22, 2023 – Saturday, September 23, 2023